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Purpose. The Federal Aviation Administration's (FAA's) Office of Aerospace Medicine evaluates present and proposed medical certification standards for pilots. Under this responsibility, the FAA Civil Aerospace Medical Institute investigates the role of potential medical-or drug-related performance impairment in pilots. In previous research, abnormal glucose levels in vitreous humor (>125 mg/dL) and urine (>100 mg/dL) have been linked with diabetic conditions in pilots of fatal aviation accidents. Although these abnormal glucose levels identify pilots with elevated blood sugar at the time of death, they do not provide information on how well diabetes was controlled in these pilots. Since post-crash factors (trauma, stress, medical intervention) can dramatically affect blood glucose levels, a measure of long-term diabetic control was sought for postmortem specimens. Methods. Blood specimens from volunteers were collected and stored at room temperature for up to 52 days to mimic a postmortem condition. These specimens were analyzed for hemoglobin A lc (HbAJ at selected time intervals during the 52-day period. Postmortem blood specimens from 34 aviation accident pilot fatalities were also analyzed. Some of these pilots had a known history of diabetes. Results. HbA lc values in blood from volunteers did not significantly change for up to 52 days. The HbA lc concentration in postmortem blood samples from pilots ranged from 3.9-10.5%. Only one pilot with a HhA lc over 6.0% did not have a history of diabetes reported to the FAA. Conclusions. HbA k is stable in whole blood stored at room temperature for 52 days and appears to be stable in postmortem blood stored up to 84 days. HbA lc above 6.0% was found to be generally correlated with a known history of diabetes and with the abnormal vitreous humor and urine glucose levels established previously. Elevated postmortem HbA, c levels may be useful in supporting determinations of medical impairment/incapacitation in transportation accidents. 
INTRODUCTION
Research into the use of hemoglobin A 1C (HbA lc ) began in the late 1960s and has continued to gain favor over the years for the diagnosis of diabetes mellitus (1-12). In fact, the analysis of HbA |C has become a routine test for the diagnosis of diabetes and the monitoring of diabetic patients. The strong correlation found between elevated HbA lc and diabetes (9) has made this analysis a very popular tool in the diagnosis and treatment of diabetics.
HbA )C is formed through the irreversible reaction of glucose with hemoglobin at the NH 2 -terminus of one or both beta chains of hemoglobin (4) and is reported as a percentage of the total hemoglobin present in the specimen. Normal non-diabetic individuals have HbA lc levels between 3-6% (11). The life expectancy of the red blood cell is 2 -3 months. Therefore, HbA )C will provide information on the patient's long-term success in treating their diabetic condition over the past 2 -3 months.
A previous study has shown a correlation between diabetic pilots and elevated postmortem vitreous humor and urine glucose levels (2). This information has helped accident investigators assess the medical condition of the pilot at the time of the accident and allowed the Office of Aviation Medicine (OAM) to closely monitor medical certification standards concerning diabetic pilots.
Vitreous humor glucose levels can be influenced by several non-diabetic factors such as stress and medications. Therefore, it would be useful to know the HbA lc level of the pilot to confirm the diagnosis of diabetes and help assess the pilot's prior control of the diabetic condition.
The analysis of blood collected from aviation accidents is complicated by the frequent delay of several weeks in receiving specimens. Autopsies are often delayed by difficulties in recovering bodies from remote accident sites, specimen collection, and sending samples to the laboratory. This delay in analysis requires that HbA ]C levels be stable in postmortem blood for extended periods of time. Earlier studies (4 -8) have reported HbA lc stability in postmortem blood collected and tested shortly after death. This study intends to examine the stability of HbA in blood stored over an extended period of time.
MATERIALS AND METHODS

Materials
All reagents and blood specimens were allowed to reach room temperature prior to analysis. A 1 uL sample of thoroughly mixed whole blood specimen was placed into the glass capillary provided in the 
Clinical Specimens
A blood sample was drawn from a known diabetic, and another sample from a non-diabetic individual. Blood was collected into tubes containing the anticoagulant EDTA and stored at room temperature. These specimens were analyzed over a period of 52 days. The collection time was noted, and analyses were performed at periodic intervals. This was done to demonstrate the stability of HbA ]C in blood stored at room temperature for an extended period of time.
Necropsy Specimens
Blood was collected by local pathologists, located near the accident site, in 10 mL gray top tubes containing 20 mg of potassium oxalate and 100 mg of sodium fluoride (Tri-Tech Inc., Southport, NC) from 34 pilots who had died in aviation accidents. Postmortem blood specimens from aviation pilots were aliquoted into tubes and frozen for analysis at a later date. HbA JC was determined in postmortem blood samples, which were 7 to 84 days old.
RESULTS
Clinical Specimens
A blood specimen taken from a known diabetic subject had an average HbA (C of 10.2 %, when tested over a period of 52 days with a 0.5 % standard deviation (n=12). A blood specimen taken from a non-diabetic subj ect had an average hemoglobin Ale of 4.9 % with standard deviation of 0.1 % (n= 12) for the same period of time (Figure 1 ).
Necropsy Specimens
HbA ]C levels above 6% were found in 8 of the 34 postmortem cases analyzed (Table 1) . A medical history of diabetes mellitus was found in 6 of the 8 cases with elevated HbA lc . One case with a 10.5% HbA )C had a medical history of glycosuria. Another pilot had a 6.7% HbA lc level and no reported medical history of diabetes. Most of the elevated HbA ]C specimens analyzed were associated with elevated glucose levels in vitreous and/or urine.
DISCUSSION AND CONCLUSION
HbA ]C levels above 6% are generally correlated with a known history of diabetes. It may also be considered diagnostic of diabetes mellitus in postmortem blood. Elevated postmortem HbA )C levels, in combination with elevated glucose levels in vitreous HbA 1G was analyzed for 52 days. The diabetic blood sample had a 407 mg/dL glucose level on the first day of the test, and the non-diabetic blood sample had a glucose level of 92 mg/dL on the first day of the test. Table 1 . HbA 1G and glucose data collected in this study. All glucose data reported in mg/dL Interval between death and analysis is reported in days. Medical refers to medical history of the individual: NO = No medical history for abnormal glucose levels; PA = Passenger no medical history on file; PM = Pilot no medical history on file; Dl = Diabetic; EM = Emergency medical treatment; GL = Glycosuria or low renal threshold; SU = surface accident, no medical history on file.
